• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每日用药与按需用药预防方案的选择:一项比利时暴露前预防示范项目的结果。

Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.

机构信息

Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.

Department of Applied Psychology, Faculty of Psychology, University of Vienna, Vienna, Austria.

出版信息

J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):186-194. doi: 10.1097/QAI.0000000000001791.

DOI:10.1097/QAI.0000000000001791
PMID:29975211
Abstract

BACKGROUND

Daily pre-exposure prophylaxis and event-driven pre-exposure prophylaxis (PrEP) are efficacious in reducing HIV transmission among men who have sex with men (MSM). We analyzed baseline data from a PrEP demonstration project "Be-PrEP-ared" in Antwerp, Belgium, to understand preferences for daily PrEP or event-driven PrEP among MSM at high risk of HIV and factors influencing their initial choice.

METHODS

Cross-sectional data from an open-label prospective cohort study, using mixed methods. Participants who preregistered online were screened for eligibility and tested for sexually transmitted infections (STIs). Eligible participants chose between daily PrEP and event-driven PrEP and reported on behavioral data through an electronic questionnaire. In-depth interviews were conducted with a selected subsample. Bivariate associations were examined between preferred PrEP regimens and sociodemographic factors, sexual behavior, and STIs at screening.

RESULTS

In total, 200 participants were enrolled between October 2015 and December 2016. Self-reported levels of sexual risk-taking before enrollment were high. STI screening revealed that 39.5% had at least 1 bacterial STI. At baseline, 76.5% of participants preferred daily PrEP and 23.5% event-driven PrEP. Feeling able to anticipate HIV risk was the most frequent reason for preferring event-driven PrEP. Regimen choice was associated with sexual risk-taking behavior in the past 3 months. Almost all participants (95.7%) considered it likely that they would change their dosing regimen the following year.

CONCLUSION

Event-driven PrEP was preferred by 23.5% of the participants, which better suits their preventive needs. Event-driven PrEP should be included in PrEP provision as a valuable alternative to daily PrEP for MSM at high risk of HIV.

摘要

背景

每日暴露前预防和事件驱动的暴露前预防(PrEP)在减少男男性行为者(MSM)中的 HIV 传播方面是有效的。我们分析了比利时安特卫普 PrEP 示范项目“Be-PrEP-ared”的基线数据,以了解高 HIV 风险的 MSM 对每日 PrEP 或事件驱动 PrEP 的偏好,以及影响他们初始选择的因素。

方法

这是一项开放标签前瞻性队列研究的横断面数据,采用混合方法。通过在线预注册的参与者接受了 HIV 感染和性传播感染(STI)的筛查。符合条件的参与者在每日 PrEP 和事件驱动 PrEP 之间进行选择,并通过电子问卷报告性行为数据。对选定的子样本进行了深入访谈。使用双变量关联分析来评估首选 PrEP 方案与社会人口统计学因素、性行为和筛查时的 STI 之间的关系。

结果

共纳入 200 名参与者,纳入时间为 2015 年 10 月至 2016 年 12 月。入组前自我报告的性风险水平较高。STI 筛查显示,39.5%的参与者至少有一种细菌 STI。基线时,76.5%的参与者首选每日 PrEP,23.5%的参与者首选事件驱动 PrEP。能够预测 HIV 风险是选择事件驱动 PrEP 的最常见原因。方案选择与过去 3 个月的性行为风险有关。几乎所有参与者(95.7%)认为他们很可能会在明年改变他们的剂量方案。

结论

23.5%的参与者首选事件驱动 PrEP,这更符合他们的预防需求。对于 HIV 高风险的 MSM,事件驱动 PrEP 应该作为每日 PrEP 的一种有价值的替代方案纳入 PrEP 服务中。

相似文献

1
Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project.每日用药与按需用药预防方案的选择:一项比利时暴露前预防示范项目的结果。
J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):186-194. doi: 10.1097/QAI.0000000000001791.
2
Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.比利时男男性行为者的日常和事件驱动型暴露前预防:一项前瞻性队列研究,测量依从性、性行为和性传播感染发病率的结果。
J Int AIDS Soc. 2019 Oct;22(10):e25407. doi: 10.1002/jia2.25407.
3
Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.男男性行为者更常选择每日而非事件驱动型使用暴露前预防措施:阿姆斯特丹示范研究的基线分析。
J Int AIDS Soc. 2018 Mar;21(3):e25105. doi: 10.1002/jia2.25105.
4
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.每日用药和按需用药预防方案下男男性行为者的性行为特征和艾滋病毒及性传播感染发病率:AMPrEP 研究两年结果。
Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.
5
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.每日用药和按需用药预防(PrEP)的男男性行为者(MSM)的性行为和性传播感染发生率:阿姆斯特丹 PrEP(AMPrEP)示范项目队列的四年随访。
PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. eCollection 2024 May.
6
Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men.选择基于事件的和每日 HIV 暴露前预防 - 来自两项男男性行为人群中 PrEP 展示项目的数据。
J Int AIDS Soc. 2021 Aug;24(8):e25768. doi: 10.1002/jia2.25768.
7
Motives for choosing, switching and stopping daily or event-driven pre-exposure prophylaxis - a qualitative analysis.选择、转换和停止每日或事件驱动的暴露前预防用药的动机 - 定性分析。
J Int AIDS Soc. 2019 Oct;22(10):e25389. doi: 10.1002/jia2.25389.
8
Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.澳大利亚有HIV暴露前预防经验的男同性恋者和双性恋男性中,与将每日使用抗生素作为性传播感染预防措施的意愿相关的因素。
Sex Transm Dis. 2023 Mar 1;50(3):144-149. doi: 10.1097/OLQ.0000000000001731. Epub 2022 Nov 6.
9
Preventing Premature Pre-Exposure Prophylaxis Discontinuation and Sexually Transmitted Infections Among Men Who Have Sex With Men (Project PEACH): Protocol for a Prospective Cohort Study.预防男男性行为者过早停止暴露前预防及性传播感染(PEACH项目):一项前瞻性队列研究方案
JMIR Res Protoc. 2025 Apr 23;14:e56096. doi: 10.2196/56096.
10
Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan.现实生活中的不完美依从:从预防有效性角度看男男性行为者日常和事件驱动的 HIV 暴露前预防用药依从性 - 台湾一项前瞻性队列研究。
J Int AIDS Soc. 2021 May;24(5):e25733. doi: 10.1002/jia2.25733.

引用本文的文献

1
Where we stand on doxyPEP depends on where we sit: a viewpoint.我们对多西环素暴露后预防(doxyPEP)的立场取决于我们所处的位置:一种观点。
Front Microbiol. 2025 Jun 20;16:1616111. doi: 10.3389/fmicb.2025.1616111. eCollection 2025.
2
Preferences for on-demand/intermittent/event-driven and long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) among HIV-negative Black gay, bisexual, and other sexual minority men in the United States: A qualitative study.美国 HIV 阴性的黑人男同性恋者、双性恋者及其他性少数男性对按需/间歇性/事件驱动型和长效注射用艾滋病毒暴露前预防(PrEP)的偏好:一项定性研究。
PLoS One. 2025 Jun 30;20(6):e0323212. doi: 10.1371/journal.pone.0323212. eCollection 2025.
3
A modeling study of pre-exposure prophylaxis to eliminate HIV in Taiwan by 2030.
一项关于到2030年在台湾通过暴露前预防来消除艾滋病毒的建模研究。
Commun Med (Lond). 2025 Apr 17;5(1):123. doi: 10.1038/s43856-025-00833-7.
4
Factors associated with retention and adherence on Pre-Exposure Prophylaxis among men who have sex with men in Kigali, Rwanda.卢旺达基加利男男性行为者中与暴露前预防的持续使用和依从性相关的因素。
PLOS Glob Public Health. 2024 Dec 31;4(12):e0004063. doi: 10.1371/journal.pgph.0004063. eCollection 2024.
5
Transforming HIV prevention: the promise of long-acting preexposure prophylaxis in high HIV burden settings.转变HIV预防方式:在高HIV负担地区长效暴露前预防的前景
Curr Opin HIV AIDS. 2025 Jan 1;20(1):32-38. doi: 10.1097/COH.0000000000000895. Epub 2024 Nov 4.
6
Reconciling advantages and difficulties: knowledge and perceptions of event-driven PrEP among young people.协调优势与困难:年轻人对基于事件的 PrEP 的知识和看法。
Rev Saude Publica. 2024 Oct 11;58(suppl 1):13s. doi: 10.11606/s1518-8787.2020054005729. eCollection 2024.
7
Preclinical and Early Clinical Development of Tenofovir Alafenamide/Elvitegravir Topical Inserts for Effective On-Demand Vaginal and Rectal HIV Prevention.用于按需有效预防阴道和直肠HIV感染的替诺福韦艾拉酚胺/elvitegravir局部插入剂的临床前和早期临床开发。
Pharmaceutics. 2024 Mar 1;16(3):348. doi: 10.3390/pharmaceutics16030348.
8
Preference and retention of daily and event-driven pre-exposure prophylaxis for HIV prevention: a prospective cohort in Can Tho city, Viet Nam.每日和事件驱动的 HIV 预防前暴露预防的偏好和保留:越南芹苴市的一项前瞻性队列研究。
BMJ Open. 2024 Feb 29;14(2):e075976. doi: 10.1136/bmjopen-2023-075976.
9
Estimation of antimicrobial resistance of Belgium, 2022.2022 年比利时抗菌药物耐药性估计。
Euro Surveill. 2024 Feb;29(7). doi: 10.2807/1560-7917.ES.2024.29.7.2300318.
10
Understanding Oral PrEP Interest, Uptake, Persistence, and Experience of Use Among Heterosexual Men in Johannesburg, South Africa: An Exploratory Pilot Study.了解南非约翰内斯堡的异性恋男性对口服 PrEP 的兴趣、接受程度、持续使用情况和使用体验:一项探索性试点研究。
AIDS Behav. 2024 Feb;28(2):564-573. doi: 10.1007/s10461-023-04246-2. Epub 2023 Dec 21.